Keryx Biopharmaceuticals Inc fka KERX

[H2R]

What the approval means:

“More than half of the approximate 30 million people in the United States living with chronic kidney disease are iron deficient, and yet, this is the only tablet that has been developed and approved specifically to address iron deficiency anemia in these patients, who are not on dialysis,” said Steven Fishbane, M.D., chief, division of kidney diseases and hypertension, department of medicine, Northwell Health in Great Neck, New York. “Starting today, physicians can prescribe an oral iron medicine to help people living with this condition, the majority of whom are not being optimally treated.”

http://investors.keryx.com/phoenix.zhtml?c=122201&p=irol-newsArticle&ID=2314886

I don't think the PPS is going to stay down like it's showing now.

Best of luck!